Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci. 2002;14:223–36.
Pfeiffer RF. Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2016;22:S119–22.
Miller N, Noble E, Jones D, Allcock L, Burn DJ. How do I sound to me? Perceived changes in communication in Parkinson’s disease. Clin Rehabil. 2008;22:14–22.
Barnish MS, Whibley D, Horton SMC, Butterfint ZR, Deane KHO. Roles of cognitive status and intelligibility in everyday communication in people with Parkinson’s disease: a systematic review. J Parkinsons Dis. 2016;6:453–62.
GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018; 17: 939–953.
Phillips DR, Feng Z. Global ageing. In: Skinner MW, Andrews GJ, Cutchin MP, editors. Geographical gerontology: perspectives, concepts, approaches. London: Routledge; 2017.
Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Hilker R. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology. 2010;74:885–92.
Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:79–84.
Vazey EM, Aston-Jones G. The emerging role of norepinephrine in cognitive dysfunctions of Parkinson’s disease. Front Behav Neurosci. 2012;6:48.
Soukup VM, Adams RL. Parkinson’s disease. In: Adams RL, Parsons OA, Culbertson JL, Nixon SJ, editors. Neuropsychology for clinical practice. Washington, D.C.: American Psychological Association; 1986.
Kuopio A-M, Marttila RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson’s disease. Mov Disord. 2000;15:216–23.
Schrag A, Jahanshahi M, Quinn N. How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord. 2000;15:1112–8.
Mosley PE, Moodie R, Dissanayaka N. Caregiver burden in Parkinson disease: a critical review of recent literature. J Geriatr Psychiatr Neurol. 2017;30:235–52.
Weir S, Samnaliev M, Kuo T-C, Tierney TS, Autiero SW, Taylor RS, Schrag A. Short- and long-term cost and utilization of health care resources in Parkinson’s disease in the UK. Mov Disord. 2018;33:974–81.
Pezzoli G, Zini M. Levodopa in Parkinson’s disease: from the past to the future. Expert Opin Pharmacother. 2010;11:637–45.
Worth PF. How to treat Parkinson’s disease in 2013. Clin Med. 2013;13:93–6.
Thanvi B, Lo N, Robinson T. Levodopa-induced dyskinesia in Parkinson’s disease: clinical features, pathogenesis, prevention and treatment. Postgrad Med J. 2007;83:384–8.
Plowman-Prine EK, Okun MS, Sapienza CM, Shrivastav R, Fernandez HH, Foote KD, Rosenbek JC. Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non-speech motor systems. Neurorehabilitation. 2009;24:131–44.
Skodda S, Visser W, Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Trans. 2010;117:195–205.
Bloem BR, de Vries NM, Ebersbach G. Non-pharmacological treatments for patients with Parkinson’s disease. Mov Disord. 2015;30:1504–20.
Herd CP, Tomlinson CL, Deane KHO, Brady MC, Smith CH, Sackley C, Clarke CE. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson’s disease. Cochrane Database Syst Rev. 2012;8:CD002812.
Atkinson-Clement C, Sadat J, Pinto S. Behavioral treatments for speech in Parkinson’s disease: meta-analyses and review of the literature. Neurodegen Disease Man. 2015;5:233–48.
Miller N, Deane KHO, Jones D, Noble E, Gibb C. National survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: therapists’ practices. Int J Lang Commun Disord. 2011;46:189–201.
Miller N, Noble E, Jones D, Burn DJ. Life with communication changes in Parkinson’s disease. Age Ageing. 2006;35:235–9.
Sapir S, Ramig LO, Fox CM. Intensive voice treatment in Parkinson’s disease: Lee Silverman voice treatment. Expert Rev Neurotherapeutics. 2011;11:815–30.
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham health profile: subjective health status and medical consultations. Soc Sci med. Part A: Medical Psychology & Medical Sociology. 1981;15:221–9.
Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurology Neurosurg Psychiatr. 1999;66:431–5.
McCarthy KF, Ondaatje EH, Zakaras L, Brooks A. Gifts of the muse: reframing the debate about the benefits of the arts. Santa Monica: RAND Research in the Arts; 2004.
Eisner E. Ten lessons the arts teach. Learning and the Arts: Crossing Boundaries Conference; 2000.
Dingle GA, Brander C, Ballantyne J, Baker FA. ‘To be heard’: the social and mental health benefits of choir singing for disadvantaged adults. Psychol Music. 2013;41:405–21.
Tajfel H, Turner JC. The social identity theory of intergroup behaviour. In: Worchel S, Austin WG, editors. Psychology of intergroup relations. Chicago: Nelson-Hall; 1986.
Hodkinson P. Media, culture and society: an introduction. London: SAGE; 2017.
Zhang Q, Hu J, Wei L, Jia Y, Jin Y. Effects of dance therapy on cognitive and mood symptoms in people with Parkinson’s disease: a systematic review and meta-analysis. Complement Ther Clin Pract. 2019;36:12–7.
Delabary MDS, Komeroski IG, Monteiro EP, Costa RR, Haas AN. Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson’s disease: a systematic review with meta-analysis. Aging Clin Exp Res. 2018;30:727–35.
Kalyani HHN, Sullivan K, Moyle GH, Brauer S, Jeffrey ER, Roeder L, Kerr G. Effects of dance on gait cognition, and dual-tasking in Parkinson’s disease: a systematic review and meta-analysis. J Parkinsons Dis. 2019;9:335–49.
Barnish J, Atkinson RA, Barran SM, Barnish MS. Potential benefit of singing for people with Parkinson’s disease: a systematic review. J Parkinsons Dis. 2016;6:473–84.
Pereira APS, Marinho V, Gupta D, Magalhães F, Ayres C, Teixeira S. Music therapy and dance as gait rehabilitation in patients with Parkinson disease: a review of evidence. J Geriatr Psychiatr Neurology. 2019;32:49–56.
Raglio A. Music therapy interventions in Parkinson’s disease; the state-of-the-art. Front Neurol. 2015;6:00185.
Raglio A, Oasi O. Music and health: what interventions for what results? Front Psychology. 2015;6:230.
Clare A, Camic PM. Live and recorded group music interventions with active participation for people with dementias: a systematic review. Arts Health. https://doi.org/10.1080/17533015.2019.1675732 [Epub ahead of print].
Katikreddy SV, Egan M, Petticrew M. How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study. J Epidemiol Community Health. 2015;69:189–95.
Mirabella G, De Vita P, Fragola M, Rampelli S, Lena F, Modugno N. Theatre is a valid add-on therapeutic intervention for emotional rehabilitation of Parkinson’s disease patients. Parkinson’s Disease. 2017;2017:7436725.
Modugno N, Iaconelli S, Fiorelli M, Lena F, Kusch I, Mirabella G. Active theater as a complementary therapy for Parkinson’s disease rehabilitation: a pilot study. Scientific World J. 2010;10:2301–13.
Pohl P, Didzar N, Hallert E. The Ronnie Gardiner rhythm and music method – a feasibility study in Parkinson’s disease. Disabil Rehabil. 2013;35:2197–04.
Spina E, Barone P, Mosca LL, Lombardi A, Longo K, Iavarone A, Amboni M. Music therapy for motor and nonmotor symptoms of Parkinson’s disease: a prospective, randomized, controlled, single-blinded study. J Am Geriatr Soc. 2016;64(9):e36–8.
Pacchetti C, Mancini F, Aglieri R, Fundarò C, Martignoni E, Nappi G. Active music therapy in Parkinson’s disease: an integrative method for motor and emotional rehabilitation. Psychosom Med. 2000;62:386393.
Pantelyat A, Syres C, Reichwein S, Willis A. DRUM-PD: the use of a drum circle to improve the symptoms and signs of Parkinson’s disease (PD). Mov Disord Clin Pract. 2016;3:243–9.
Tamplin J, Morris ME, Marigliani C, Baker FA, Vogel AP. ParkinSong: a controlled trial of singing-based therapy for Parkinson’s disease. Neurorehabil Neural Repair. 2019;33:453–63.
Tamplin J, Vogel A, Marigliani C, Baker F, Morris M. A controlled trial of ParkinSong singing groups to improve communication and wellbeing in Parkinson’s disease [abstract]. Mov Disord. 2018;33(S2):S138.
Matthews R, Purdy S, Tippett L. Acoustic, respiratory, cognitive and wellbeing comparisons of two groups of people with Parkinson’s disease participating in voice and choral singing group therapy (VCST) versus music appreciation activity [abstract]. Mov Disord. 2018;33(S2):S406.
Volpe D, Signorini M, Marchetto A, Lynch T, Morris ME. A comparison of Irish set dancing and exercises for people with Parkinson’s disease: a phase II feasibility study. BMC Geriatr. 2013;13:54.
De Natale ER, Paulus KS, Aiello E, Sanna B, Manca A, Sotgiu G, Leali PT, Deriu F. Dance therapy improves motor and cognitive functions in patients with Parkinson’s disease. NeuroRehabilitation. 2017;40:141–4.
Hackney ME, Kantorovich S, Earhart GM. A study of the effects of argentine tango as a form of partnered dance for those with Parkinson disease and the healthy elderly. Am J Dance Ther. 2007;29(2):109–27.
Hackney ME, Kantorovich S, Levin R, Earhart GM. Effects of tango on functional mobility in Parkinson’s disease: a preliminary study. J Neurologic Physical Ther. 2007;31:173–9.
Hashimoto H, Takabatake S, Miyaguchi H, Nakanishi H, Naitou Y. Effects of dance on motor functions, cognitive functions, and mental symptoms of Parkinson’s disease: a quasi-randomized pilot trial. Complement Ther Med. 2015;23:210–9.
Rawson KS, McNeely ME, Duncan RP, Pickett KA, Perlmutter JS, Earhart GM. Exercise and Parkinson’s disease: comparing tango, treadmill and stretching. J Neurologic Physical Ther. 2019;43(1):26–32.
Romenets SR, Anang J, Fereshtehnejad SM, Pelletier A, Postuma R. Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: a randomized control study. Complement Ther Med. 2015;23:175–84.
Westbrook BK, McKibben H. Dance/movement therapy with groups of outpatients with Parkinson’s disease. Am J Dance Ther. 1989;11(1):27–38.
Hackney M, Hart A, Kim C. It takes two to tango but following may be more beneficial for rehabilitating people with mild-moderate Parkinson’s [abstract]. Mov Disord. 2018;33(S2):S149.
McKee KE, Hackney ME. The effects of adapted tango on spatial cognition and disease severity in Parkinson’s disease. J Motor Behav. 2013:45(6). https://doi.org/10.1080/00222895.2013.834288.
Patel R, Hart A, Hackney M, Kim C. Partnered, rhythmic, rehabilitative movement may impact medication related motor fluctuations [abstract]. Ann Neurol. 2018;84(S22):S201.
Michels K, Dubaz O, Hornthal E, Bega D. “Dance therapy” as a psychotherapeutic movement intervention in Parkinson’s disease. Complement Ther Med. 2018;40:248–52.
Michels K, Hornthal E, Bega D. A pilot study on dance/movement therapy in Parkinson’s disease [Abstract]. Neurology. 2018;90:15, S1.
Duncan RP, Earhart GM. Are the effects of community-based dance on Parkinson disease severity, balance, and functional mobility reduced with time? A 2-year prospective pilot study. J Altern Complement Med. 2014;20:757–63.
Duncan RP, Earhart GM. Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabilitation Neural Repair. 2012;26(2):132–43.
Foster ER, Golden L, Duncan RP, Earhart GM. A community-based argentine tango dance program is associated with increased activity participation among individuals with Parkinson disease. Arch Phys Med Rehabil. 2013;94(2):240–9.
Hackney ME, Earhart GM. Effects of dance on movement control in Parkinson’s disease: a comparison of argentine tango and American ballroom. J Rehabil Med. 2009;41:475–81.
Hackney ME, Earhart GM. Health-related quality of life and alternative forms of exercise in Parkinson disease. Parkinsonism Relat Disord. 2009;15:644–8.
Hackney ME, Earhart GM. Short duration, intensive tango dancing for Parkinson disease: an uncontrolled pilot study. Complement Ther Med. 2009;17(4):203–7.
Hulbert S, Ashburn A, Roberts L, Verheyden G. Dance for Parkinson’s – the effects on whole body co-ordination during turning around. Complement Ther Med. 2017;32:91–7.
Kalyani HHN, Sullivan KA, Moyle G, Brauer S, Jeffrey ER, Kerr GK. Impacts of dance on cognition, psychological symptoms and quality of life in Parkinson’s disease. NeuroRehabilitation. 2019;45:273–83.
Kunkel D, Fitton C, Roberts L, Pickering RM, Roberts HC, Wiles R, Ashburn A. A randomized controlled feasibility trial exploring partnered ballroom dancing for people with Parkinson’s disease. Clin Rehabil. 2017;31:1340–50.
McGill A, Houston S, Lee RYW. Effects of a ballet-based dance intervention on gait variability and balance confidence of people with Parkinson’s. Arts Health. 2019;11(2):133–46.
Shanahan J, Morris ME, Ni Bhriain O, Volpe D, Richardson M, Clifford AM. Is Irish set dancing feasible for people with Parkinson’s disease in Ireland? Complement Ther Med. 2015;21:47–51.
Solla P, Cugusi L, Bertoli M, Cereatti A, Della Croce U, Pani D, Mercuro G. Sardinian folk dance for individuals with Parkinson’s disease: a randomized controlled pilot trial. J Altern Complement Med. 2019;25:305–16.
Ventura MI, Barnes DE, Ross JM, Lanni KE, Sigvardt KA, Disbrow EA. A pilot study to evaluate multi-dimensional effects of dance for people with Parkinson’s disease. Contemp Clin Trials. 2016;51:50–5.
Zafar M, Bozzorg A, Hackney ME. Adapted tango improves aspects of participation in older adults versus individuals with Parkinson’s disease. Disabil Rehabil. 2017;39:2294–301.
Lee HJ, Kim SY, Chae Y, Kim MY, Yin C, Jung WS, Lee H. Turo (qi dance) program for Parkinson’s disease patients: randomized, assessor blind, waiting-list control, partial crossover study. Explore. 2018;14:216–23.
Shanahan J, Morris ME, Ni Bhriain O, Volpe D, Lynch T, Clifford A. Dancing for Parkinson’s disease: a randomized controlled trial of Irish set dancing compared with usual care. Arch Phys Med Rehabil. 2017;98:1744–51.
Westheimer O. Why dance for Parkinson’s disease. Topics in Geriatric Rehabilitation. 2008;24:27–140.
Koch SC, Mergheim K, Raeke J, Machado CB, Riegner E, Nolden J, Hillecke TK. The embodied self in Parkinson’s disease: feasibility of a single tango intervention for assessing changes in psychological health outcomes and aesthetic experience. Front Neurosci. 2016;10:287.
Irons JY, Hancox G, Vella-Burrows T, Han EY, Chong HJ, Sheffield D, Stewart DE. Group singing improves quality of life for people with Parkinson’s: an international study. Aging Ment Health. https://doi.org/10.1080/13607863.2020.1720599.
Irons Y, Hancox G, Vella-Burrows T, Han EY, Ching HJ, Sheffield D, Stewart D. Group singing improves quality of life in people with Parkinson’s: an international Sing to Beat Parkinson’s project [Abstract]. J Parkinsons Dis. 2019;9:186.
Stegemöller EL, Hibbing P, Radig H, Wingate J. Therapeutic singing as an early intervention for swallowing in persons with Parkinson’s disease. Complement Ther Med. 2017;31:127–33.
Stegemöller EL, Radig H, Hibbing P, Wingate J, Sapienza C. Effects of singing on voice, respiratory control and quality of life in persons with Parkinson’s disease. Disabil Rehabil. 2017;39:594–600.
Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well-being for individuals with Parkinson’s disease. Qual Life Res. 1995;4:241–8.
WHOQOL Group. Development of the WHOQOL: rationale and current status. Int J Ment Health. 1994;23:24–56.
Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13:557–69.
McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, Bricker DE. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17(2):97–114.
Shih LC, Piel J, Warren A, Krasics L, Silver A, Vanderhorst V, Tarsy D. Singing in groups for Parkinson’s disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders. Parkinsonism Relat Disord. 2012;18:548–52.
Tanner M, Rammage L, Liu L. Does singing and vocal strengthening improve vocal ability in people with Parkinson’s disease? Arts Health. 2016;8(3):199–212.
Elefant C, Baker FA, Lotan M, Lagesen SK, Skeie GO. The effect of group music therapy on mood, speech, and singing in individuals with Parkinson’s disease – a feasibility study. J Music Ther. 2012;49:278–302.
Elefant C, Lotan M, Baker FA, Skeie GO. Effects of music therapy on facial expression of individuals with Parkinson’s disease: a pilot study. Musicae Scientae. 2012;13:392–400.
Prewitt CM, Charpentier JC, Brosky JA, Urbscheit NL. Effects of dance classes on cognition, depression, and self-efficacy in Parkinson’s disease. Am J Dance Ther. 2017;39:126–41.
Batson G, Migliarese SJ, Soriano C, Burdette JH, Laurienti PJ. Effects of improvisational dance on balance in Parkinson’s disease: a two-phase fMRI case study. Phys Occupat Ther Geriatr. 2014;32(3):188–97.
Fahn S, Elton RL, UPDRS program members. Unified Parkinson’s disease rating scale. In: S Fahn, CD Marsden, M Goldstein & DB Calne, Recent developments in Parkinson’s disease. Florham Park, NJ: Macmillan Healthcare Information, 1987.
Holdsworth N. Boys don’t dance, do they? Res Drama Educ. 2013;18(2):168–78.
Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk of Parkinson’s disease than women? J Neurol Neurosurg Psychiatry. 2004;75:637–9.
Faure-Delage A, Mouanga AM, M’belesso P, Tabo A, Bandzouzi B, Dubreuil CM, Nubupko P. Socio-cultural perceptions and representations of dementia in Brazzaville, republic of Congo: the EDAC survey. Dementia Geriatr Cogn Dis Extra. 2012;2:84–96.
Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson’s disease: the potential of a social relational approach to disablism. Parkinsons Dis. 2013;2013:608562.
Tickle-Degnen L, Zebrowitz LA, Ma H. Culture, gender and health care stigma: practitioners’ response to facial masking experienced by people with Parkinson ‘s disease. Soc Sci Med. 2011;73:95–102.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, LaPelle N. Movement Disorder Society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70.
Berg K, Wood-Dauphinée S, Williams JI, Gayton D. Measuring balance in the elderly: preliminary development of an instrument. Physiother Can. 1989;41:304–11.
Podsiadlo D, Richardson S. The timed “up & go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.
Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Nasreddine Z, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, MoCA: brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Battery AIT. Manual of directions and scoring. Washington, DC: War Department, Adjutant General’s Office; 1944.
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–6.
Heiberger L, Maurer C, Amtage F, Mendez-Balbuena I, Schulte-Mönting J, Hepp-Raymond MC, Kristeva R. Impact of a weekly dance class on the functional mobility and on the quality of life of individuals with Parkinson’s disease. Front Aging Neurosci. 2011;3:14.
EuroQoL Group. EuroQoL – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Newman CW. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol. 1997;6(3):66–70.
Eadie TL, Yorkston KM, Klasner ER, Dudgeon BJ, Deitz JC, Baylor CR, Miller RM, Amtmann D. Measuring communicative participation: a review of self-report instruments in speech-language pathology. Am J Speech Lang Pathol. 2006;15(4):307–20.
Yorkston KM, Klasner ER, Swanson KM. Communication in context: a qualitative study of the experiences of individuals with multiple sclerosis. Am J Speech Lang Pathol. 2001;10:126–37.
Danielsen AK, Pommergaard HC, Burcharth J, Angenete E, Rosenberg J. Translation of questionnaires measuring health related quality of life is not standardized: a literature based study. PLoS One. 2015;10:e0127050.
Barnish MS, Turner S. The value of pragmatic and observational studies in health care and public health. Pragmat Obs Res. 2017;8:49–55.
Pring T. Ask a silly question: two decades of troublesome trials. Int J Lang Commun Disord. 2004;39:285–302.
Smelt AFH, van der Weele GM, Blom JW, Gussekloo J, Assendelft WJJ. How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials. Brit J Gen Pract. 2010;60:e305–18.
Drinkwater C, Wildman J, Moffatt S. Social prescribing. BMJ. 2019;364:l1285.
Marinus J, Visser M, Verwey NA, Middelkoop HA, Stiggelbout AM, van Hilten JJ. Assessment of cognition in Parkinson’s disease. Neurology. 2003;61:1222–8.
World Health Organization. International classification of functioning, disability and health: ICF. World Health Organization, 2001. https://apps.who.int/iris/handle/10665/42407.
Baylor C, Yorkston K, Eadie T, Jim J, Chung H, Amtmann D. The communicative participation item Bank (CPIB): item bank calibration and development of a disorder-general short form. Journal of Speech, Language, and Hearing Research. 2013;56:1190–208.
Baylor C, McAuliffe MJ, Hughes LE, Yorkston K, Anderson T, Kim J, Amtmann D. A differential item function (DIF) analysis of the communicative participation item Bank (CPIB): comparing individuals with Parkinson’s disease from the United States and New Zealand. J Speech Lang Hear Res. 2014;57:90–5.
Donovan NJ, Kendall DL, Young ME, Rosenbek JC. The communicative effectiveness survey: preliminary evidence of construct validity. Am J Speech Lang Pathol. 2008;17:335–47.
Donovan NJ. Examining the item-level psychometric properties of the communicative effectiveness survey-revised for people with Parkinson’s disease and dysarthria. Clin Arch Commun Disord. 2018;3:42–51.
Barnish MS, Horton SMC, Butterfint ZR, Clark AB, Atkinson RA, Deane KHO. Speech and communication in Parkinson’s disease: a cross-sectional exploratory study in the UK. BMJ Open. 2017;7:e014642.
McAuliffe MJ, Baylor CR, Yorkston KM. Variable associated with communicative participation in Parkinson’s disease and its relationship to measures of health-related quality of life. Int J Speech Lang Pathol. 2017;19:407–17.